Data as of Aug 20
| -0.04 / -1.07%|
The 1 analysts offering 12-month price forecasts for Aastrom Biosciences Inc have a median target of 4.25, with a high estimate of 4.25 and a low estimate of 4.25. The median estimate represents a +14.56% increase from the last price of 3.71.
The current consensus among 4 polled investment analysts is to Hold stock in Aastrom Biosciences Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.